In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 27th, 2004 | 21 | Yes |
Popular Name: 5-[(2,5-dihydroxybenzyl)amino]-2-hydroxy-benzoic-acid-methyl-ester 5-[(2,5-dihydroxybenzyl)amino]-2…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.80 | 0.08 | -11.33 | 4 | 6 | 0 | 99 | 289.287 | 5 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR-2-E | Epidermal Growth Factor Receptor ErbB1 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 600 | 0.41 | Binding ≤ 10μM |
LCK-3-E | Tyrosine-protein Kinase LCK (cluster #3 Of 4), Eukaryotic | Eukaryotes | 600 | 0.41 | Binding ≤ 10μM |
EGFR-2-E | Epidermal Growth Factor Receptor ErbB1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 9000 | 0.34 | Functional ≤ 10μM |
Z80840-1-O | ER22 Cell Line (cluster #1 Of 1), Other | Other | 600 | 0.41 | Binding ≤ 10μM |
Z80840-1-O | ER22 Cell Line (cluster #1 Of 1), Other | Other | 9000 | 0.34 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1000 | 0.40 | Binding ≤ 1μM |
Z80840 | Z80840 | ER22 Cell Line | 1000 | 0.40 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 600 | 0.41 | Binding ≤ 1μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1000 | 0.40 | Binding ≤ 10μM |
Z80840 | Z80840 | ER22 Cell Line | 1000 | 0.40 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 600 | 0.41 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 9000 | 0.34 | Functional ≤ 10μM |
Z80840 | Z80840 | ER22 Cell Line | 9000 | 0.34 | Functional ≤ 10μM |
Description | Species |
---|---|
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
Downstream TCR signaling | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
GAB1 signalosome | |
Generation of second messenger molecules | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
Interleukin-2 signaling | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
PLCG1 events in ERBB2 signaling | |
Regulation of KIT signaling | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by SCF-KIT | |
Translocation of ZAP-70 to Immunological synapse |